Eden Research (LON:EDEN) Trading Down 13.2% – Here’s Why

Posted by ABMN Staff on Apr 1st, 2025

Eden Research plc (LON:EDEN – Get Free Report) shares dropped 13.2% during mid-day trading on Monday . The company traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares were traded during trading, an increase of 133% from the average daily volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Stock Down 2.1 %

The business has a 50 day moving average of GBX 3.39 and a 200 day moving average of GBX 3.72. The firm has a market capitalization of £12.27 million, a price-to-earnings ratio of -8.06 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42.

Insider Activity at Eden Research

In other news, insider Lykele van der Broek bought 256,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The stock was bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($13,229.97). Also, insider Alexander John Abrey purchased 540,540 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,934.88). Insiders have purchased a total of 964,487 shares of company stock valued at $3,690,001 in the last 90 days. 14.02% of the stock is owned by corporate insiders.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.